CrossrefInfokarte
ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report
OncoTargets and Therapy · 2026-11 · Volume 19 · 1-10
DOI: 10.2147/ott.s653854 ↗Abstract
Kein Abstract verfügbar.
EUVIMED